These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1643653)

  • 1. Glucuronoxylomannan of Cryptococcus neoformans serotype C: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
    Cherniak R; Morris LC; Meyer SA
    Carbohydr Res; 1992 Mar; 225(2):331-7. PubMed ID: 1643653
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucuronoxylomannan of Cryptococcus neoformans serotype D: structural analysis by gas-liquid chromatography-mass spectrometry and by 13C-nuclear magnetic resonance spectroscopy.
    Cherniak R; Morris LC; Turner SH
    Carbohydr Res; 1992 Jan; 223():263-9. PubMed ID: 1596924
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
    Turner SH; Cherniak R
    Carbohydr Res; 1991 Apr; 211(1):103-16. PubMed ID: 1773425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete assignment of the 1H- and 13C-n.m.r. spectra of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype B.
    Skelton MA; van Halbeek H; Cherniak R
    Carbohydr Res; 1991 Dec; 221():259-68. PubMed ID: 1816923
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
    Turner SH; Cherniak R; Reiss E; Kwon-Chung KJ
    Carbohydr Res; 1992 Sep; 233():205-18. PubMed ID: 1446309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67.
    Vaishnav VV; Bacon BE; O'Neill M; Cherniak R
    Carbohydr Res; 1998 Jan; 306(1-2):315-30. PubMed ID: 9691456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy.
    Sheng S; Cherniak R
    Carbohydr Res; 1997 Jun; 301(1-2):33-40. PubMed ID: 9228737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucuronoxylomannan of Cryptococcus neoformans obtained from patients with AIDS.
    Cherniak R; Morris LC; Meyer SA; Mitchell TB
    Carbohydr Res; 1993 Nov; 249(2):405-13. PubMed ID: 8275508
    [No Abstract]   [Full Text] [Related]  

  • 9. Galactoxylomannans of Cryptococcus neoformans.
    James PG; Cherniak R
    Infect Immun; 1992 Mar; 60(3):1084-8. PubMed ID: 1541523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy.
    Bacon BE; Cherniak R
    Carbohydr Res; 1995 Oct; 276(2):365-86. PubMed ID: 8542606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of glycoinositolphosphoryl ceramide structure mutant strains of Cryptococcus neoformans.
    Gutierrez AL; Farage L; Melo MN; Mohana-Borges RS; Guerardel Y; Coddeville B; Wieruszeski JM; Mendonça-Previato L; Previato JO
    Glycobiology; 2007 Jun; 17(6):1-11C. PubMed ID: 17369287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans.
    Cherniak R; Morris LC; Anderson BC; Meyer SA
    Infect Immun; 1991 Jan; 59(1):59-64. PubMed ID: 1987064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy.
    Bacon BE; Cherniak R; Kwon-Chung KJ; Jacobson ES
    Carbohydr Res; 1996 Mar; 283():95-110. PubMed ID: 8901265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid.
    Heiss C; Klutts JS; Wang Z; Doering TL; Azadi P
    Carbohydr Res; 2009 May; 344(7):915-20. PubMed ID: 19345342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.
    Ikeda R; Matsuyama H; Nishikawa A; Shinoda T; Fukazawa Y
    Microbiol Immunol; 1991; 35(2):125-38. PubMed ID: 1886490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile syntheses of the hexasaccharide repeating unit of the exopolysaccharide from Cryptococcus neoformans serovar A.
    Zhang J; Kong F
    Bioorg Med Chem; 2003 Sep; 11(18):4027-37. PubMed ID: 12927865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of the exocellular polysaccharide from the cyanobacterium Cyanospira capsulata.
    Garozzo D; Impallomeni G; Spina E; Sturiale L
    Carbohydr Res; 1998 Feb; 307(1-2):113-24. PubMed ID: 9658567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of oligosaccharides corresponding to structures found in capsular polysaccharides of Cryptococcus neoformans--II.
    Garegg PJ; Olsson L; Oscarson S
    Bioorg Med Chem; 1996 Nov; 4(11):1867-71. PubMed ID: 9007271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of the O-specific polysaccharide from Hafnia alvei strain 38 lipopolysaccharide.
    Katzenellenbogen E; Romanowska E; Witkowska D; Shashkov AS
    Carbohydr Res; 1992 Jul; 231():51-4. PubMed ID: 1394327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the exopolysaccharide of Pseudomonas stutzeri strain ATCC 17588.
    Osman SF; Fett WF; Dudley RL
    Carbohydr Res; 1994 Dec; 265(2):319-22. PubMed ID: 7842450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.